Subscribe To
SILK / Silk Road Medical to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
SILK News
By The Motley Fool
October 11, 2023
Why Shares of Silk Road Medical Are Dropping Wednesday
Silk Road Medical is a medical device company that focuses on preventing strokes. The company released preliminary third-quarter numbers and reduced y more_horizontal
By Proactive Investors
October 11, 2023
Silk Road Medical stock plummets on CEO exit and revenue downgrade
Silk Road Medical (NASDAQ:SILK) stock halved in value at the start of Wednesday's trading after an after-hours profit warning. The company, which has more_horizontal
By InvestorPlace
October 11, 2023
Why Is Silk Road Medical (SILK) Stock Down 40% Today?
Silk Road Medical (NASDAQ: SILK ) stock is falling hard on Wednesday after the medical device company released preliminary earnings results for Q3 20 more_horizontal
By Barrons
October 11, 2023
Silk Road Medical Stock Sinks. Here's Why Citi Says Sell.
Two pieces of news are weighing on shares of the medical devices company. more_horizontal
By Market Watch
October 10, 2023
Silk Road Medical stock falls following outlook, CEO's retirement
Silk Road Medical Inc. SILK, -0.71% shares dropped in the extended session Tuesday after the medical device company updated its forecast and said its more_horizontal
By GlobeNewsWire
September 4, 2023
Silk Road Medical to Present at the CL King 21st Annual Best Ideas Conference
SUNNYVALE, Calif., Sept. 04, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and i more_horizontal
By Seeking Alpha
August 1, 2023
Silk Road Medical, Inc. (SILK) Q2 2023 Earnings Call Transcript
Silk Road Medical, Inc. (NASDAQ:SILK ) Q2 2023 Earnings Conference Call August 1, 2023 4:30 PM ET Company Participants Marissa Bych - Investor Relatio more_horizontal
By Zacks Investment Research
August 1, 2023
Silk Road Medical (SILK) Reports Q2 Loss, Tops Revenue Estimates
Silk Road Medical (SILK) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to lo more_horizontal